| human | Q5 |
| P2798 | Loop ID | 334414 |
| P3835 | Mendeley person ID | jason-r-plemel |
| P496 | ORCID iD | 0000-0003-1385-1464 |
| P69 | educated at | University of British Columbia | Q391028 |
| P108 | employer | University of Alberta | Q640694 |
| University of Calgary | Q1067471 | ||
| P734 | family name | Plemel | Q36941061 |
| Plemel | Q36941061 | ||
| Plemel | Q36941061 | ||
| P735 | given name | Jason | Q2630093 |
| Jason | Q2630093 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | male | Q6581097 |
| Q47810587 | A graded forceps crush spinal cord injury model in mice. |
| Q35127777 | A systematic review of cellular transplantation therapies for spinal cord injury |
| Q35999574 | An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination |
| Q47978691 | Axo-myelinic neurotransmission: a novel mode of cell signalling in the central nervous system |
| Q35909149 | Axonal thinning and extensive remyelination without chronic demyelination in spinal injured rats |
| Q58452226 | Biochemically altered myelin triggers autoimmune demyelination |
| Q39261219 | Cell transplantation therapy for spinal cord injury. |
| Q90732168 | Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells |
| Q48157412 | Combination of olfactory ensheathing cells with local versus systemic cAMP treatment after a cervical rubrospinal tract injury |
| Q47549630 | Deficient Surveillance and Phagocytic Activity of Myeloid Cells Within Demyelinated Lesions in Ageing Mice Visualized by Ex Vivo Live Multiphoton Imaging. |
| Q38228967 | Immune modulatory therapies for spinal cord injury--past, present and future. |
| Q35057728 | Intermittent fasting improves functional recovery after rat thoracic contusion spinal cord injury. |
| Q51239312 | Intermittent fasting in mice does not improve hindlimb motor performance after spinal cord injury. |
| Q58454971 | Locomotor recovery following contusive spinal cord injury does not require oligodendrocyte remyelination |
| Q48001723 | Mechanisms of lysophosphatidylcholine-induced demyelination: A primary lipid disrupting myelinopathy |
| Q102973318 | Microglia Diversity in Health and Multiple Sclerosis |
| Q93055838 | Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion |
| Q48303959 | Motor axonal regeneration following cord transection. |
| Q50477254 | Myelin inhibits oligodendroglial maturation and regulates oligodendrocytic transcription factor expression. |
| Q38718081 | Myelin regulatory factor drives remyelination in multiple sclerosis |
| Q48172017 | Myelinogenic Plasticity of Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury |
| Q58454974 | Neutrophil Contribution in Facilitating Optic Nerve Regeneration |
| Q38569263 | Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review. |
| Q50501021 | Platelet-derived growth factor-responsive neural precursors give rise to myelinating oligodendrocytes after transplantation into the spinal cords of contused rats and dysmyelinated mice. |
| Q92535375 | Progressive multiple sclerosis: from pathophysiology to therapeutic strategies |
| Q38192321 | Remyelination after spinal cord injury: is it a target for repair? |
| Q39420410 | Remyelination therapies: a new direction and challenge in multiple sclerosis |
| Q125342816 | Single-cell microglial transcriptomics during demyelination defines a microglial state required for lytic carcass clearance |
| Q34679913 | Skin-derived precursors generate myelinating Schwann cells that promote remyelination and functional recovery after contusion spinal cord injury. |
| Q92745530 | The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury |
| Q50552179 | The molecular physiology of the axo-myelinic synapse. |
| Q38713422 | Unique spectral signatures of the nucleic acid dye acridine orange can distinguish cell death by apoptosis and necroptosis. |
Search more.